Decentralized Trials STREAM

  1. Modernizing Clinical Research With Patient-Centric Digital Data Collection 2/25/2025

    Accelerate clinical trial modernization with streamlined collection of continuous, high-precision data centered on the patient.

  2. The New Vaccine Race: Why A Decentralized Approach Wins 3/29/2022

    What does it take to get vaccine trials up and running quickly and efficiently? As it turns out, the best answer is DCT. Learn why in the available webinar.

  3. Patient First Solutions For Oncology 2/14/2023

    Medable, Inc's new oncology offering is an end-to-end suite that includes an extensive eCOA library, pre-built and validated DCT applications such as Total Consent and Televisit, and protocol design consulting.

  4. Collect Better Oncology Trial Data, Easier 3/29/2022

    In this webinar, experts discuss how enriching oncology clinical trials with RWD generates deeper insights and improves operational efficiency to achieve better patient outcomes.

  5. Elevating The Site Voice 3/27/2025

    A decentralized trial can be daunting for sites, but Medidata offers solutions to help site staff, sponsors, and patients move smoothly through the clinical trial process.

  6. Everything You Need To Know About Hybrid/Decentralized Trials 7/20/2022

    This webinar provides insight into an understanding of hybrid and decentralized clinical trials (DCT), the facts and fiction around decentralized trials, and why decentralized trials are not an all or nothing approach.

  7. DCTs: The Site Perspective 5/8/2024

    Putting patients and sites on the same platform coordinates and simplifies eCOA patient data collection and provides a 360 degree view of the patient. See how through Dr. Aaliyah's story.

  8. Medable Total Consent: The Future Of Informed Consent 2/14/2023

    With Total Consent, Medable is transforming the consenting process – harmonizing it into one simple-to-use platform that enables trial sponsors and CROs to completely customize eConsent.

  9. Are You Realizing ROI Across Your Portfolio Of Studies? 9/20/2022

    Research shows that the global DCT market will reach $14B by 2026. Research also suggests that up to 90% of clinical trials are at risk of failure. Faulty trial designs, patient retention, costs and flawed data collection are drivers for the failure rate in clinical trials. The risks of study failure are reduced by taking a patient- first enterprise platform approach.

  10. How State-Of-The-Art Clinical Trial Mobile Vision Clinics Work 3/11/2025

    Are you seeking a non-traditional option to complete the eye exams necessary for your ocular clinical trials? A mobile clinic may be the solution you're looking for.